Earn CME: https://www.naccme.com/program/19-lm-14 In this webcast from the ‘Revolutionizing the R/R DLBCL Treatment Paradigm: Innovative, Strategic & Targeted Approaches’ symposium during the 2019 Lymphoma & Myeloma conference in New York, Dr. John P. Leonard discusses the current state of upfront management of diffuse large b-cell lymphoma (DLBCL). © 2019 Imedex, an HMP Company
Current Upfront Management of DLBCL
